Epperly Melissa B,
CIK 0001807359 Name as filed on the most recent filing
Filed as Epperly Melissa B, (19)
52 transaction lines · from 19 filings · filed 2020-11-25 to 2026-07-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
52 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-29 |
Roivant Sciences Ltd. ROIV |
S, Open-market sale | 15,002 disposed | 34.32 | 514,868.64 | Form 4, filing 0001807359-26-000010 | |
| 2026-06-29 |
Roivant Sciences Ltd. ROIV |
S, Open-market sale | 2,748 disposed | 34.71 | 95,383.08 | Form 4, filing 0001807359-26-000010 | |
| 2026-03-16 |
Roivant Sciences Ltd. ROIV |
S, Open-market sale | 41,861 disposed | 28.68 | 1,200,573.48 | Form 4, filing 0001807359-26-000004 | |
| 2024-02-12 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,573 disposed | 11.44 | 29,435.12 | Form 4, filing 0001725160-24-000043 | |
| 2024-02-02 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 8,669 disposed | 11.54 | 100,040.26 | Form 4, filing 0001725160-24-000028 | |
| 2023-10-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,594 disposed | 19.43 | 89,245.34 | Form 4, filing 0001725160-23-000179 | |
| 2023-10-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 888 disposed | 19.91 | 17,680.26 | Form 4, filing 0001725160-23-000179 | |
| 2023-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,227 disposed | 19.98 | 104,410.89 | Form 4, filing 0001725160-23-000035 | |
| 2023-02-13 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,624 disposed | 20.42 | 53,593.63 | Form 4, filing 0001725160-23-000035 | |
| 2022-04-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 8,094 disposed | 48.75 | 394,562.26 | Form 4, filing 0001725160-22-000069 | |
| 2022-04-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,512 disposed | 51.99 | 234,561.73 | Form 4, filing 0001725160-22-000069 | |
| 2022-04-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,818 disposed | 50.70 | 142,865.56 | Form 4, filing 0001725160-22-000069 | |
| 2022-04-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,303 disposed | 49.90 | 65,022.05 | Form 4, filing 0001725160-22-000069 | |
| 2022-04-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 353 disposed | 52.44 | 18,510.83 | Form 4, filing 0001725160-22-000069 | |
| 2022-02-23 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,211 disposed | 48.81 | 59,109.27 | Form 4, filing 0001725160-22-000047 | |
| 2022-02-23 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 702 disposed | 49.59 | 34,811.48 | Form 4, filing 0001725160-22-000047 | |
| 2021-08-19 |
Zentalis Pharmaceuticals, Inc. ZNTL |
P, Open-market purchase | 8,285 acquired | 52.00 | 430,800.12 | Form 4, filing 0001725160-21-000185 | |
| 2021-08-18 |
Zentalis Pharmaceuticals, Inc. ZNTL |
P, Open-market purchase | 1,326 acquired | 52.00 | 68,948.02 | Form 4, filing 0001725160-21-000185 | |
| 2021-07-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,378 disposed | 51.15 | 70,479.33 | Form 4, filing 0001725160-21-000163 | |
| 2021-07-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 805 disposed | 52.01 | 41,864.99 | Form 4, filing 0001725160-21-000163 | |
| 2021-07-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 700 disposed | 50.10 | 35,073.01 | Form 4, filing 0001725160-21-000163 | |
| 2021-07-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 200 disposed | 53.18 | 10,637.00 | Form 4, filing 0001725160-21-000163 | |
| 2021-06-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,883 disposed | 53.99 | 155,660.95 | Form 4, filing 0001725160-21-000135 | |
| 2021-06-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 200 disposed | 54.90 | 10,980.00 | Form 4, filing 0001725160-21-000135 | |
| 2021-05-03 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,122 disposed | 60.14 | 67,479.88 | Form 4, filing 0001725160-21-000120 | |
| 2021-05-03 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 950 disposed | 59.83 | 56,839.16 | Form 4, filing 0001725160-21-000120 | |
| 2021-05-03 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 661 disposed | 58.04 | 38,367.68 | Form 4, filing 0001725160-21-000120 | |
| 2021-05-03 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 350 disposed | 56.99 | 19,948.00 | Form 4, filing 0001725160-21-000120 | |
| 2021-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 13,792 disposed | 43.37 | 598,099.73 | Form 4, filing 0001725160-21-000090 | |
| 2021-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,083 disposed | 43.43 | 133,895.61 | Form 4, filing 0001725160-21-000090 | |
| 2021-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 149 disposed | 44.21 | 6,588.01 | Form 4, filing 0001725160-21-000090 | |
| 2021-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 83 disposed | 45.06 | 3,740.03 | Form 4, filing 0001725160-21-000090 | |
| 2021-03-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,083 disposed | 41.67 | 128,482.48 | Form 4, filing 0001725160-21-000050 | |
| 2021-02-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,700 disposed | 37.45 | 101,122.56 | Form 4, filing 0001725160-21-000022 | |
| 2021-02-01 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 383 disposed | 38.33 | 14,682.11 | Form 4, filing 0001725160-21-000022 | |
| 2021-01-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,583 disposed | 52.73 | 83,477.45 | Form 4, filing 0001725160-21-000005 | |
| 2021-01-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 800 disposed | 50.36 | 40,287.04 | Form 4, filing 0001725160-21-000005 | |
| 2021-01-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 600 disposed | 51.58 | 30,949.32 | Form 4, filing 0001725160-21-000005 | |
| 2021-01-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 100 disposed | 53.20 | 5,320.00 | Form 4, filing 0001725160-21-000005 | |
| 2020-12-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,983 disposed | 53.71 | 267,642.41 | Form 4, filing 0001725160-20-000059 | |
| 2020-12-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 971 disposed | 52.53 | 51,005.95 | Form 4, filing 0001725160-20-000059 | |
| 2020-12-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 391 disposed | 54.39 | 21,265.04 | Form 4, filing 0001725160-20-000059 | |
| 2020-12-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 119 disposed | 50.84 | 6,049.84 | Form 4, filing 0001725160-20-000059 | |
| 2020-12-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,877 disposed | 51.17 | 198,396.95 | Form 4, filing 0001725160-20-000059 | |
| 2020-12-04 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,343 disposed | 50.76 | 169,699.71 | Form 4, filing 0001725160-20-000059 | |
| 2020-12-02 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,525 disposed | 51.33 | 78,273.22 | Form 4, filing 0001725160-20-000048 | |
| 2020-12-02 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 700 disposed | 50.34 | 35,237.02 | Form 4, filing 0001725160-20-000048 | |
| 2020-12-02 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 500 disposed | 52.27 | 26,136.00 | Form 4, filing 0001725160-20-000048 | |
| 2020-12-02 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 358 disposed | 53.17 | 19,034.54 | Form 4, filing 0001725160-20-000048 | |
| 2020-11-23 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,783 disposed | 46.51 | 129,436.50 | Form 4, filing 0001725160-20-000042 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 3
- Open-market sale 49
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Epperly Melissa B,, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001807359
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6